Primary Trastuzumab-Resistance After (Neo)Adjuvant Trastuzumab-Containing Treatment for HER2-Positive Breast Cancer Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Breast Cancer